It is a pharma public limited company based in Chennai, Tamil Nadu, India, established in 2006.
2006 | Chennai, Tamil Nadu, India | ActiveApollo Clinical Excellence Solutions Limited, a active public limited company, was established on 14 September 2006 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U85110TN2006PLC061112. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sridhar Rohini (Director), Lodugureddygari Lakshminarayanareddy (Director), Anupam Sibal (Director). Past directors included Preetha Reddy, Sangita Reddy, Lodugureddygari Lakshminarayanareddy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 3Rd Floor, Ali Towers, No.55 Greams Road, Thousand Lights,, Chennai, Tamil Nadu, 600006.
U85110TN2006PLC061112
061112
14 September 2006
₹1.00 Cr
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Apollo Clinical Excellence Solutions Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sridhar Rohini | Director | 30 Sep 2024 | Current |
| Lodugureddygari Lakshminarayanareddy | Director | 15 Nov 2014 | Current |
| Anupam Sibal | Director | 14 Sep 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Sep 2024 | Past |
| Pramod Abcsdd | Director | 15 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apollo Clinical Excellence Solutions Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 50.18% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Apollo Clinical Excellence Solutions had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Apollo Clinical Excellence Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Apollo Clinical Excellence Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apollo Clinical Excellence Solutions's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Apollo Clinical Excellence Solutions Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Sridhar Rohini was appointed as a Director was appointed as a Director on 30 Sep 2024 & has been associated with this company since 1 year 1 month . was documented.
Apollo Clinical Excellence Solutions Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on Lodugureddygari Lakshminarayanareddy was appointed as a Director was appointed as a Director on 15 Nov 2014 & has been associated with this company since 11 years 10 days . was documented.
The activity Anupam Sibal was appointed as a Director was appointed as a Director on 14 Sep 2006 & has been associated with this company since 19 years 2 months . was completed.
Apollo Clinical Excellence Solutions Limited was registered on 14 Sep 2006 with Roc Chennai & aged 19 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Apollo Clinical Excellence Solutions Limited is U85110TN2006PLC061112.
Apollo Clinical Excellence Solutions Limited is headquartered at 3Rd Floor, Ali Towers, No.55 Greams Road, Thousand Lights,, Chennai, Tamil Nadu, 600006.
Apollo Clinical Excellence Solutions Limited was incorporated on 14 September 2006.
The current directors of Apollo Clinical Excellence Solutions Limited are
The primary industry of Apollo Clinical Excellence Solutions Limited is Pharma.
Apollo Clinical Excellence Solutions Limited is unlisted.
The authorized capital of Apollo Clinical Excellence Solutions Limited is ₹1.00 Cr, and the paid-up capital is ₹0.50 M.
The compliance status of Apollo Clinical Excellence Solutions Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX